Oct. 5, 2022
by Irina Bilous, Andrii Buvailo
Biopharma insight
(Last updated: October 05, 2022) The interest of pharma organizations in DNA-encoded chemical libraries (DEL) technology has been growing over …
Today, Insilico Medicine, a leading player in artificial intelligence (AI)-driven drug discovery and longevity research, tops up its recent $60 …
July 19, 2022
by Natalia Honchar, Andrii Buvailo
Biopharma insight
Shuimu BioSciences, a biotech start-up working towards the implementation of cryo-EM into drug discovery, got an investment from the internet …
July 11, 2022
by Tim Sandle
Biopharma insight
The digital transformation of biopharmaceutical manufacturing has continued at a rapid pace as companies mine the rich sources of data …
July 6, 2022
by Andrii Buvailo, Irina Bilous
Biopharma insight
It took more than eight decades since the landmark experiments on calorie restrictions in 1930th to get to a point …
May 30, 2022
by Andrii Buvailo
Biopharma insight
Using virtual reality (VR) for manipulating 3D models of small molecules and large biomolecules in the context of drug design …
April 25, 2022
by Andrii Buvailo
Biopharma insight
What is “artificial intelligence”? Artificial intelligence (AI) is an interdisciplinary science concerned with building “intelligent agents”, the field which takes …
Feb. 21, 2022
by Andrii Buvailo
Biopharma insight
The first biologics drug, humanized insulin (5.8 kDa), became available in 1982 following the advent of biotechnology, and it marked …
Feb. 8, 2022
by Andrii Buvailo
Biopharma insight
Since the early days of the pharmaceutical industry, small molecules have been the most extensively used group of drugs. Nowadays, …
Jan. 24, 2022
by Chris De Savi
Biopharma insight
Antimicrobial resistance (AMR) poses a major threat to human health. There were an estimated 4.95M deaths associated with bacterial AMR …
Jan. 21, 2022
by Andrii Buvailo
Biopharma insight
In November 2021, the parent company of Google, Alphabet, Inc., announced the launch of a new commercial subsidiary in the …
Dec. 3, 2021
by Andrii Buvailo
Biopharma insight
Getting a step closer to treating Idiopathic Pulmonary Fibrosis A Hong Kong-based company applying a state-of-the-art artificial intelligence (AI) platform …